{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:49:30Z","timestamp":1774612170306,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jviromet.2023.114856","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T13:54:55Z","timestamp":1700661295000},"page":"114856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Performance characteristics of Allele-Specific PCR (ASPCR) in detecting drug resistance mutations among non-B HIV-1 Variants"],"prefix":"10.1016","volume":"323","author":[{"given":"Chatt\u00e9","family":"Adawaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Fokam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick Ntambwe","family":"Kamangu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick Tambe Ayuk","family":"Ngwese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Susin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mahamat","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BertinTchombou","family":"Hig-Zounet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mad-Toingu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelsalam","family":"Tidjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Moutschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2023.114856_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-017-2893-1","article-title":"Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N\u2019Djamena, Chad: findings from a cross-sectional study","volume":"10","author":"Adawaye","year":"2017","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jviromet.2023.114856_bib2","unstructured":"Ameziane, N., Bogard, M., Lamoril, J., 2006. Principes de biologie mol\u00e9culaire en biologie clinique, Campus r\u00e9f\u00e9rence."},{"key":"10.1016\/j.jviromet.2023.114856_bib3","first-page":"22","article-title":"US surveillance of HIV drug resistance at diagnosis using HIV diagnostic sera","author":"Bennett","year":"2005","journal-title":"12th Conf. Retrovir. Opportunistic Infect."},{"key":"10.1016\/j.jviromet.2023.114856_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/135965350400900420","article-title":"Clinically validated genotype analysis: guiding principles and statistical concerns","author":"Brun-V\u00e9zinet","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2023.114856_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3851\/IMP1687","article-title":"HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysis","volume":"16","author":"Buckton","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2023.114856_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0761-8417(11)70004-9","article-title":"Prelevement et recherche de la mutation EGFR: quoi pr?lever, quand et comment tester","volume":"67","author":"Cadranel","year":"2011","journal-title":"Rev. Pneumol. Clin."},{"key":"10.1016\/j.jviromet.2023.114856_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965350200700301","article-title":"Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial","volume":"7","author":"Calvez","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2023.114856_bib8","first-page":"51","article-title":"R\u00e9sistance du VIH aux antir\u00e9troviraux: \u00e9valuations virologiques des th\u00e9rapeutiques","volume":"1998","author":"Damond","year":"1998","journal-title":"Rev. Fr. Des. Lab."},{"key":"10.1016\/j.jviromet.2023.114856_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111042","article-title":"Minority drug-resistant HIV-1 variants in treatment Na\u00efve East-African and Caucasian patients detected by allele-specific real-time PCR","volume":"9","author":"Ekici","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2023.114856_bib10","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-60327-411-1_26","article-title":"Allele-specific PCR in SNP genotyping","author":"Gaudet","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jviromet.2023.114856_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug\u2010resistant HIV","volume":"202","author":"Gianella","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114856_bib13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.41.4.1586-1593.2003","article-title":"Accuracy of the TRUGENE HIV-1 Genotyping Kit","volume":"41","author":"Grant","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114856_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00019048-200205000-00060","article-title":"Time trends in primary Hiv-1 drug resistance among recently infected persons","volume":"11","author":"Grant","year":"2002","journal-title":"Infect. Dis. Clin. Pract."},{"key":"10.1016\/j.jviromet.2023.114856_bib15","first-page":"3389","article-title":"Allele-specific real-time PCR testing for minor HIV-1 drug resistance mutations: assay preparation and application to reveal dynamic of mutations in vivo","volume":"123","author":"Guo","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jviromet.2023.114856_bib16","first-page":"229","article-title":"Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy","volume":"49","author":"Gutsche","year":"2004","journal-title":"Surv. Anesth."},{"key":"10.1016\/j.jviromet.2023.114856_bib17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/JCM.00449-06","article-title":"Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency","volume":"44","author":"Halvas","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114856_bib18","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/AAC.01672-08","article-title":"Detection and quantification of minor human immunodeficiency virus type 1 variants harboring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR","volume":"53","author":"Hauser","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2023.114856_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/589297","article-title":"Antiretroviral drug resistance testing in adult HIV\u20101 infection: 2008 recommendations of an international AIDS society\u2013USA panel","volume":"47","author":"Hirsch","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114856_bib20","doi-asserted-by":"crossref","first-page":"F111","DOI":"10.1097\/00002030-200007280-00001","article-title":"Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission","volume":"14","author":"Jackson","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib21","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-na\u00efve populations and associate with reduced treatment efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jviromet.2023.114856_bib22","first-page":"156","article-title":"Update of the drug resistance mutations in HIV-1: December 2010","volume":"18","author":"Johnson","year":"2010","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.jviromet.2023.114856_bib23","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.89.5.1934","article-title":"Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine","volume":"89","author":"Kellam","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jviromet.2023.114856_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00126334-200405010-00008","article-title":"Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens","volume":"36","author":"Kuritzkes","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"80","key":"10.1016\/j.jviromet.2023.114856_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.2479983","article-title":"Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)","volume":"246","author":"Larder","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2023.114856_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-199102000-00002","article-title":"Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes","volume":"5","author":"Larder","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00126334-200501010-00007","article-title":"Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine","volume":"38","author":"Lecossier","year":"2005","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2023.114856_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.aids.0000222071.60620.1d","article-title":"Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission","volume":"20","author":"Loubser","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/379215","article-title":"Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions","volume":"188","author":"Metzner","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114856_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.aids.0000189878.97480.ed","article-title":"Detection of minor populations of drug-resistant HIV-1 in acute seroconverters","volume":"19","author":"Metzner","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"Palmer","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2023.114856_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jviromet.2007.06.012","article-title":"Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations","volume":"146","author":"Paredes","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2023.114856_bib33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy","volume":"22","author":"Peuchant","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib34","first-page":"1235","article-title":"Use of coefficient of variation in assessing variability of quantitative assays","volume":"9","author":"Reed","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jviromet.2023.114856_bib35","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/jvi.68.3.1660-1666.1994","article-title":"Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy","volume":"68","author":"Richman","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2023.114856_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.patbio.2008.04.004","article-title":"HIV genetic diversity and its consequences","volume":"57","author":"Roquebert","year":"2009","journal-title":"Pathol. Biol. (Paris)."},{"key":"10.1016\/j.jviromet.2023.114856_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/48.1.113","article-title":"Distribution of K103N and\/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors","volume":"48","author":"Torti","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jviromet.2023.114856_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0888-7543(92)90292-Z","article-title":"Application of an allele-specific polymerase chain reaction to the direct determination of ABO blood group genotypes","volume":"12","author":"Ugozzoli","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.jviromet.2023.114856_bib39","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/00002030-200212060-00003","article-title":"The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses","volume":"16","author":"Wei","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2023.114856_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0042-6822(03)00173-9","article-title":"Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis","volume":"311","author":"Wei","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2023.114856_bib41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/378281","article-title":"Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates","volume":"188","author":"Whitcomb","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2023.114856_bib42","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1073\/pnas.86.8.2757","article-title":"Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia","volume":"86","author":"Wu","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jviromet.2023.114856_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3727\/000000004783983729","article-title":"Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo","volume":"13","author":"Yang","year":"2004","journal-title":"Cell Transpl."},{"key":"10.1016\/j.jviromet.2023.114856_bib44","unstructured":"Yeni, P., 2008. Rapport du Groupe d\u2019Experts 2008 sur la prise en charge m\u00e9dicale des patients infect\u00e9es par le VIH, sous la direction du Pr Patrick Yeni. Paris."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093423001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:57:35Z","timestamp":1759057055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093423001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"alternative-id":["S0166093423001817"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114856","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance characteristics of Allele-Specific PCR (ASPCR) in detecting drug resistance mutations among non-B HIV-1 Variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2023.114856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114856"}}